Abstract:
A method of enhancing fluorescence emission in a fluorophore-mediated sensing, biosensing, imaging, and bioimaging. An example of biosensing is a fluorophore-mediated sandwich immunoassay with a 1° monoclonal antibody against a target analyte and a fluorophore-linked 2° monoclonal antibody, exposing the immunoassay to an enhancing agent, applying excitation light to the immunoassay, and measuring an emission signal from the immunoassay.
Abstract:
The present invention relates to a plasma display apparatus, which includes a front substrate; a plurality of first, second electrodes formed on the front substrate; a rear substrate that is faced with the front substrate; a plurality of third electrodes formed on the rear substrate; and a discharge cell that is disposed in the place where the first, the second electrode intersect with the third electrode, wherein at least one of the first and the second electrode is formed with one layer, wherein the width or the length of the first and the second electrode arranged in the adjacent discharge cells are different each other. Accordingly, the manufacturing cost can be decreased by eliminating the transparent electrode made of ITO, the color temperature and the luminance of the plasma display panel ca be increased by asymmetrically forming R, G, B discharge cell.
Abstract:
A biosensor device that includes a module defining at least one microfluidic channel, an optical waveguide exposed along at least a portion of its length to fluid flow within the microfluidic channel, where a surface of the optical waveguide being prepared to bind a target biomarker, and an excitation source to couple an excitation wavelength of light into the optical waveguide. The device also includes a sensor for detecting emission light from the optical waveguide at an emission wavelength characteristic of binding of the target biomarker. Particular devices include multiple waveguides in multiple microfluidic channels. Particular devices include microfluidic channels with serpentine bump structures that aid molecular transport.
Abstract:
A method of controlling a portable device including at least one foldable panel and first and second touch screens is provided. The method includes displaying, on the first touch screen, a first page designated as a home screen and an icon related to at least one application, and a dock area, and displaying, on the second touch screen, first information in a state where the foldable panel is unfolded. The method also includes replacing the first page and the dock area with an outgoing call screen, receiving a phone number input, replacing the outgoing call screen with a dialing screen, and displaying, on the second touch screen, a guide message indicating to fold the portable device for a call. The method also includes replacing the dialing screen with a mid-call screen, and removing the guide message displayed on the second touch screen, and displaying the first information.
Abstract:
A flexible display apparatus and a method of displaying a User Interface (UI) are provided. The flexible display apparatus includes an exposed area determining unit for determining an exposed screen area facing outwards with respect to the flexible display apparatus; a User Interface (UI) generating unit for generating a UI corresponding to the outwardly facing exposed screen area; and a display unit for displaying the generated UI on the outwardly facing exposed screen area.
Abstract:
A method and apparatus for inputting various operation instructions to a device including two movable panels. The method includes determining whether a relative angle between the first panel and the second panel is within an effective angle range; determining whether the relative angle within the effective angle range is maintained during an effective time; and inputting an operation instruction to the device based on whether the relative angle between the first panel and the second panel is within the effective angle range and whether the relative angle within the effective angle range is maintained during the effective time.
Abstract:
The present invention relates to a plasma display apparatus. The plasma display apparatus includes an upper substrate, a scan electrode, a sustain electrode, a dielectric layer, a lower substrate, and address electrodes. The scan and sustain electrodes are formed on the upper substrate, and the dielectric layer covers the scan and sustain electrodes. The lower substrate faces the upper substrate, and the address electrodes are formed on the lower substrate. In plasma display apparatus, at least one of the scan and sustain electrodes is formed as one layer. A reset signal including a gradually falling setdown period is supplied to the scan electrode more than two times in at least one reset period among a plurality of subfields.
Abstract:
A method and apparatus for displaying information on at least two touch screens are provided. The method includes sensing a first touch-drag on a first touch screen; sensing a first touch on a second touch screen; and displaying, on at least one of the first and second touch screens, information corresponding to the first touch-drag on the first touch screen and the touch on the second touch screen, if the touch-drag on the first touch screen and the first touch on the second touch screen are simultaneously sensed.
Abstract:
A method of enhancing fluorescence emission in a fluorophore-mediated sensing, biosensing, imaging, and bioimaging. An example of biosensing is a fluorophore-mediated sandwich immunoassay with a 1° monoclonal antibody against a target analyte and a fluorophore-linked 2° monoclonal antibody, exposing the immunoassay to an enhancing agent, applying excitation light to the immunoassay, and measuring an emission signal from the immunoassay.
Abstract:
A method of enhancing fluorescence emission in a fluorophore-mediated sensing, biosensing, imaging, and bioimaging. An example of biosensing is a fluorophore-mediated sandwich immunoassay with a 1° monoclonal antibody against a target analyte and a fluorophore-linked 2° monoclonal antibody, exposing the immunoassay to an enhancing agent, applying excitation light to the immunoassay, and measuring an emission signal from the immunoassay.